"Cline Symposium: Oklahoma Law Could Force Doctors To Provide Substandard Medical Care to Women Using Medications To End a Pregnancy," Jennifer Blasdell/Nancy Stanwood, SCOTUSblog: "At stake in Cline v. Oklahoma Coalition for Reproductive Justice is the ability of a woman to use medications to end a pregnancy" and "the right of a clinician to provide the best and most up-to-date medical care to a patient," write Blasdell -- a senior director at Physicians for Reproductive Health -- and Stanwood, PRH board chair. They note that Oklahoma is urging the Supreme Court to uphold a state law (HB 1970) that restricts the application of the medication abortion drug mifepristone to its original FDA label. However, research has shown that the drug is "equally effective at lower dosages than the regimen in the 2000 label," that the second dose is safe to take at home and that medication abortion is safe "in the first nine weeks from the last menstrual period, two weeks beyond the original research given to the FDA," Blasdell and Stanwood write. "These evidence-based regimes have become standard medical practice in the U.S. and abroad," they add, urging the justices to "recognize this law for what it is -- an unjustified political intrusion into the practice of medicine that threatens the health and well-being of women across this country and forces health care providers to violate their ethics and practice outdated medicine" (Blasdell/Stanwood, SCOTUSblog, 9/20).
What others are saying about abortion access:
~ "Why It's Important To Talk About Later-Term Abortion," Sarah Erdreich, Huffington Post blogs.
~ "Abortion Opponents Are Now Going After Hospitals That Don't Even Perform Abortions," Robin Marty, Care2.
~ "Guest Post: 97% of OB/GYNs Will Have a Patient Who Needs an Abortion, But Only 14% Perform Them," Dusenbery, Feministing.
"California Governor was Right To Veto Bill Allowing Researchers To Pay Women for Their Eggs," Marcy Darnovsky/Susan Berke Fogel, Our Bodies Ourselves' "Our Bodies, Our Blog": Darnovsky -- executive director at the Center for Genetics and Society -- and Berke Fogel -- co-founder of the Pro-Choice Alliance for Responsible Research -- praise California Gov. Jerry Brown (D) for vetoing a bill that would have allowed researchers to pay women for their eggs. They write that Brown astutely rejected the bill on the grounds that "'informed consent is difficult because the long term risks are not adequately known,'" but supporters of the measure unfairly criticized him as siding with groups that are religious, antiabortion-rights and anti-science. Darnovsky and Berke Fogel note that many opponents of the bill were in fact "pro-choice groups and individuals." They also point out that research has not yet adequately addressed many questions about egg donation, such as how it affects women's future fertility. The authors call for "well-designed, prospective studies of the effects of egg retrieval" before expanding the market for eggs (Darnovsky/Berke Fogel, "Our Bodies, Our Blog," Our Bodies Ourselves, 9/5).